0	12	Constitutive	constitutive	JJ
13	21	NF-kappa	NF-kappa	NNP
22	23	B	B	NNP
24	34	activation	activation	NN
34	35	,	,	,
36	44	enhanced	enhance	VBN
45	59	granulopoiesis	granulopoiesis	NN
59	60	,	,	,
61	64	and	and	CC
65	73	neonatal	neonatal	JJ
74	83	lethality	lethality	NN
84	86	in	in	IN
87	88	I	i	NN
89	94	kappa	kappa	NN
95	96	B	B	NNP
97	112	alpha-deficient	alpha-deficient	JJ
113	117	mice	mouse	NNS
117	118	.	.	.

120	133	Transcription	Transcription	NNP
134	141	factors	factor	NNS
142	151	belonging	belong	VBG
152	154	to	to	TO
155	158	the	the	DT
159	167	NF-kappa	NF-kappa	NNP
168	169	B	B	NNP
170	176	family	family	NN
177	180	are	be	VBP
181	191	controlled	control	VBN
192	194	by	by	IN
195	205	inhibitory	inhibitory	JJ
206	207	I	i	NN
208	213	kappa	kappa	NN
214	215	B	B	NNP
216	224	proteins	protein	NNS
224	225	,	,	,
226	232	mainly	mainly	RB
233	234	I	i	NN
235	240	kappa	kappa	NN
241	242	B	B	NNP
243	248	alpha	alpha	NN
249	252	and	and	CC
253	254	I	i	NN
255	260	kappa	kappa	NN
261	262	B	B	NNP
263	267	beta	beta	NN
267	268	.	.	.

269	279	Apparently	apparently	RB
280	286	normal	normal	JJ
287	289	at	at	IN
290	295	birth	birth	NN
295	296	,	,	,
297	298	I	i	NN
299	304	kappa	kappa	NN
305	306	B	B	NNP
307	315	alpha-/-	alpha-/-	JJ
316	320	mice	mouse	NNS
321	328	exhibit	exhibit	VBP
329	335	severe	severe	JJ
336	343	runting	runting	NN
343	344	,	,	,
345	349	skin	skin	NN
350	357	defects	defect	NNS
357	358	,	,	,
359	362	and	and	CC
363	372	extensive	extensive	JJ
373	387	granulopoiesis	granulopoiesis	NN
388	399	postnatally	postnatally	RB
399	400	,	,	,
401	410	typically	typically	RB
411	416	dying	die	VBG
417	419	by	by	IN
420	421	8	8	CD
422	426	days	day	NNS
426	427	.	.	.

428	441	Hematopoietic	hematopoietic	JJ
442	449	tissues	tissue	NNS
450	454	from	from	IN
455	460	these	these	DT
461	465	mice	mouse	NNS
466	473	display	display	VBP
474	482	elevated	elevated	JJ
483	489	levels	level	NNS
490	492	of	of	IN
493	497	both	both	CC
498	505	nuclear	nuclear	JJ
506	514	NF-kappa	NF-kappa	NNP
515	516	B	B	NNP
517	520	and	and	CC
521	526	mRNAs	mrna	NNS
527	529	of	of	IN
530	534	some	some	DT
534	535	,	,	,
536	539	but	but	CC
540	543	not	not	RB
544	547	all	all	DT
547	548	,	,	,
549	554	genes	gene	NNS
555	562	thought	think	VBN
563	565	to	to	TO
566	568	be	be	VB
569	578	regulated	regulate	VBN
579	581	by	by	IN
582	590	NF-kappa	NF-kappa	NNP
591	593	B.	B.	NNP
594	602	NF-kappa	NF-kappa	NNP
603	604	B	B	NNP
605	614	elevation	elevation	NN
615	622	results	result	VBZ
623	625	in	in	IN
626	631	these	these	DT
632	642	phenotypic	phenotypic	JJ
643	656	abnormalities	abnormality	NNS
657	664	because	because	IN
665	669	mice	mouse	NNS
670	677	lacking	lack	VBG
678	682	both	both	CC
683	684	I	i	NN
685	690	kappa	kappa	NN
691	692	B	B	NNP
693	698	alpha	alpha	NN
699	702	and	and	CC
703	706	the	the	DT
707	710	p50	p50	NN
711	718	subunit	subunit	NN
719	721	of	of	IN
722	730	NF-kappa	NF-kappa	NNP
731	732	B	B	NNP
733	737	show	show	VBP
738	739	a	a	DT
740	752	dramatically	dramatically	RB
753	760	delayed	delay	VBN
761	766	onset	onset	NN
767	769	of	of	IN
770	783	abnormalities	abnormality	NNS
783	784	.	.	.

785	787	In	in	IN
788	796	contrast	contrast	NN
797	799	to	to	TO
800	813	hematopoietic	hematopoietic	JJ
814	819	cells	cell	NNS
819	820	,	,	,
821	822	I	i	NN
823	828	kappa	kappa	NN
829	830	B	B	NNP
831	839	alpha-/-	alpha-/-	JJ
840	849	embryonic	embryonic	JJ
850	861	fibroblasts	fibroblast	NNS
862	866	show	show	VBP
867	874	minimal	minimal	JJ
875	887	constitutive	constitutive	JJ
888	896	NF-kappa	NF-kappa	NNP
897	898	B	B	NNP
898	899	,	,	,
900	902	as	as	RB
903	907	well	well	RB
908	910	as	as	IN
911	917	normal	normal	JJ
918	934	signal-dependent	signal-dependent	JJ
935	943	NF-kappa	NF-kappa	NNP
944	945	B	B	NNP
946	956	activation	activation	NN
957	961	that	that	WDT
962	964	is	be	VBZ
965	976	concomitant	concomitant	JJ
977	981	with	with	IN
982	983	I	i	NN
984	989	kappa	kappa	NN
990	991	B	B	NNP
992	996	beta	beta	NN
997	1008	degradation	degradation	NN
1008	1009	.	.	.

1010	1013	Our	our	PRP$
1014	1021	results	result	NNS
1022	1030	indicate	indicate	VBP
1031	1035	that	that	IN
1036	1037	I	i	NN
1038	1043	kappa	kappa	NN
1044	1045	b	b	NN
1046	1050	beta	beta	NN
1050	1051	,	,	,
1052	1055	but	but	CC
1056	1059	not	not	RB
1060	1061	I	i	NN
1062	1067	kappa	kappa	NN
1068	1069	B	B	NNP
1070	1075	alpha	alpha	NN
1075	1076	,	,	,
1077	1079	is	be	VBZ
1080	1088	required	require	VBN
1089	1092	for	for	IN
1093	1096	the	the	DT
1097	1113	signal-dependent	signal-dependent	JJ
1114	1124	activation	activation	NN
1125	1127	of	of	IN
1128	1136	NF-kappa	NF-kappa	NNP
1137	1138	B	B	NNP
1139	1141	in	in	IN
1142	1153	fibroblasts	fibroblast	NNS
1153	1154	.	.	.

1155	1162	However	however	RB
1162	1163	,	,	,
1164	1165	I	i	NN
1166	1171	kappa	kappa	NN
1172	1173	B	B	NNP
1174	1179	alpha	alpha	NN
1180	1182	is	be	VBZ
1183	1191	required	require	VBN
1192	1195	for	for	IN
1196	1199	the	the	DT
1200	1213	postinduction	postinduction	NN
1214	1224	repression	repression	NN
1225	1227	of	of	IN
1228	1236	NF-kappa	NF-kappa	NNP
1237	1238	B	B	NNP
1239	1241	in	in	IN
1242	1253	fibroblasts	fibroblast	NNS
1253	1254	.	.	.

1255	1260	These	these	DT
1261	1268	results	result	NNS
1269	1275	define	define	VBP
1276	1284	distinct	distinct	JJ
1285	1290	roles	role	NNS
1291	1294	for	for	IN
1295	1298	the	the	DT
1299	1302	two	two	CD
1303	1308	forms	form	NNS
1309	1311	of	of	IN
1312	1313	I	i	NN
1314	1319	kappa	kappa	NN
1320	1321	B	B	NNP
1322	1325	and	and	CC
1326	1337	demonstrate	demonstrate	VBP
1338	1341	the	the	DT
1342	1351	necessity	necessity	NN
1352	1355	for	for	IN
1356	1365	stringent	stringent	JJ
1366	1373	control	control	NN
1374	1376	of	of	IN
1377	1385	NF-kappa	NF-kappa	NNP
1386	1387	B	B	NNP
1387	1388	.	.	.